Cargando…

Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France

Detalles Bibliográficos
Autores principales: Zedan, Hadeel T., Nasrallah, Gheyath K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435264/
https://www.ncbi.nlm.nih.gov/pubmed/34525435
http://dx.doi.org/10.1016/j.ebiom.2021.103580
_version_ 1783751756530843648
author Zedan, Hadeel T.
Nasrallah, Gheyath K.
author_facet Zedan, Hadeel T.
Nasrallah, Gheyath K.
author_sort Zedan, Hadeel T.
collection PubMed
description
format Online
Article
Text
id pubmed-8435264
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84352642021-09-13 Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France Zedan, Hadeel T. Nasrallah, Gheyath K. EBioMedicine Commentary Elsevier 2021-09-12 /pmc/articles/PMC8435264/ /pubmed/34525435 http://dx.doi.org/10.1016/j.ebiom.2021.103580 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Zedan, Hadeel T.
Nasrallah, Gheyath K.
Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
title Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
title_full Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
title_fullStr Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
title_full_unstemmed Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
title_short Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France
title_sort is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with sars-cov-2? a seroprevalence cross-sectional study in north-eastern france
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435264/
https://www.ncbi.nlm.nih.gov/pubmed/34525435
http://dx.doi.org/10.1016/j.ebiom.2021.103580
work_keys_str_mv AT zedanhadeelt ispreexistingimmunitytoseasonalcoronaviruseslimitedtocrossreactivitywithsarscov2aseroprevalencecrosssectionalstudyinnortheasternfrance
AT nasrallahgheyathk ispreexistingimmunitytoseasonalcoronaviruseslimitedtocrossreactivitywithsarscov2aseroprevalencecrosssectionalstudyinnortheasternfrance